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Neutrophilia is a condition commonly observed in patients with late-stage tuberculo-
sis, but evidence suggests that increased neutrophil influx begins early after infection 
in susceptible hosts and functions to promote a nutrient-replete niche that promotes 
Mycobacterium tuberculosis survival and persistence. As the disease progresses, an 
increase in the number of neutrophil-like cells is observed, all of which exhibit characte-
ristics associated with (i) phenotypic and biochemical features of immaturity, (ii) the inabi-
lity to activate T-cells, (iii) hyper-inflammation, and (iv) prolonged survival. Transcriptomics 
reveal a common set of molecules associated with the PI3–Kinase pathway that are 
dysregulated in patients with active tuberculosis. Closer inspection of their individual 
biological roles reveal their ability to modulate the IL-17/G–CSF axis, induce leukocyte 
receptor activation, and regulate apoptosis and motility. This review draws attention to 
neutrophil hyper-reactivity as a driving force for both the establishment and progression 
of tuberculosis disease in susceptible individuals.
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iNTRODUCTiON
Evidence to date suggests a link between the advanced stages of tuberculosis and neutrophilia. In 
order for neutrophils to accumulate within the lung, an orderly procession of cell–endothelial interac-
tion, transcellular or pericellular transmigration, and some degree of enhanced survival or defective 
egress is required. Overall, evidence points toward a disruption in some of these key events during 
advanced tuberculosis disease. Multiple studies suggest that neutrophils play a protective role in the 
prevention of tuberculosis and report antimycobacterial effects in a number of in vivo studies (1–3). 
It has also been shown that neutrophil-derived bactericidal molecules kill Mycobacterium tuberculosis 
in vitro (4, 5). Human studies further reveal that higher neutrophil counts are protective against early 
tuberculosis infection (6), thus during the initial stages infection of infection, neutrophils play a 
protective role; however, a pathogenic role for neutrophils during the late stages of tuberculosis has 
been proposed (7). Neutrophilia has been assigned as a predictor of disease progression, pulmonary 
destruction, and even death (6, 8–13). The neutrophil/lymphocyte ratio (NLR) is able to distinguish 
tuberculosis patients from tuberculin skin test-positive healthy contacts (8) and predict pulmonary 
tuberculosis retreatment (14). Additionally, the significance of neutrophils during active tuberculosis 
is highlighted by the fact that the blood transcriptional signature of tuberculosis is neutrophil-driven 
and effectively distinguishes tuberculosis from other inflammatory diseases (15). Neutrophils have, 
FigURe 1 | Neutrophil recruitment into the lung in resistant and susceptible individuals over time in early and advanced stages of Mycobacterium tuberculosis 
infection. In resistant individuals, neutrophil influx occurs soon after infection, where along with macrophages, aid in removing M. tuberculosis effectively. Neutrophil 
numbers return to baseline and a minimal effect on the host is observed. In susceptible individuals, phase I begins soon after infection and is characterized as 
T cell-independent, non-specific, and transient with the potential for pathogen clearance. Phase II is characterized as T cell-dependant, specific, and ongoing and is 
associated with disease severity and pathology. During this stage, and as the disease progresses, an increase in the number of neutrophil-like cells (NLC) circulating 
in the blood and those from lung tissue are observed. They present as immature or undifferentiated precursor cells in the form of myeloid-derived suppressor cells 
(MDSC), tuberculosis-associated neutrophils (TBAN), low-density neutrophils, and band neutrophils. The second phase of exacerbated neutrophil influx is also 
associated with lung cavitation and disease progression.
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however, been shown to mediate an early inflammatory response 
that is critical for controlling M. tb infection. Thus, in the very early 
stages, evidence suggests that in resistant individuals, neutrophils 
are likely to control M. tb infection in a more effective manner 
than in susceptible individuals. It should also be noted, however, 
that not all patients with tuberculosis exhibit neutrophilia. In 
those that do, it is observed that various sub-sets of neutrophils 
exist with differing phenotypic characteristics.
Neutrophil influx to the lung after M. tb infection occurs in two 
phases in susceptible individuals (Figure 1): the first phase begins 
soon after infection and is characterized as T cell-independent, 
non-specific, and transient with the potential for pathogen 
clearance (16–18). The second phase is characterized as T cell-
dependant, specific, and ongoing and is associated with disease 
severity and pathology (13, 19, 20). During this stage, and as the 
disease progresses, an increase in the number of neutrophil-like 
cells (NLC) circulating in the blood and those from lung tissue are 
observed. They present as immature or undifferentiated precur-
sor cells in the form of myeloid-derived suppressor cells (MDSC) 
(21–23), tuberculosis-associated neutrophils (TBAN) (23), low-
density neutrophils (24), and band neutrophils (20). The role of 
these precursor/immature neutrophils at the infection site gener-
ates a number of questions with regards to their phagocytic abili-
ties. In other words, they are able to phagocytose M. tb, but fail to 
eliminate the bacteria, or they do not phagocytose mycobacteria, 
but rather associate with T-cells (25). The mechanisms underly-
ing this second phase of exacerbated neutrophil infiltration into 
the lungs is largely unknown. During acute infection, in immune-
competent individuals, neutrophil chemotaxis is controlled by 
a fine balance between mitogen-activated protein kinase (p38 
MAPK) (26) and phosphatidylinositol 3-kinase (PI3-K) signal-
ing. Briefly, when neutrophils are activated by chemoattractants, 
PI3-K phosphorylates phosphatidylinositol 4,5-bisphosphate 
(PIP2) into phosphatidylinositol (3,4,5)-trisphosphate (PIP3), 
which promotes their directional migration (27). Any perturba-
tions in the expression of these genes coding for components of 
PI3-K pathway, including its regulators may disrupt neutrophil 
trafficking and lead to neutrophil hyperreactivity (28).
In this review, attention is drawn to the link between neutro-
phil hyperreactivity and the progression of tuberculosis disease 
as a characteristic of the susceptible host. Further, common char-
acteristics of these neutrophils across mouse and human studies 
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are highlighted. A closer look at transcriptomic studies in human 
and mouse models of tuberculosis reveals altered expression 
levels of members of the PI3-kinase family and support not only 
a possible mechanism underpinning neutrophil hyperreactivity 
but may also explain the ineffectiveness of the adaptive immune 
response observed during tuberculosis. Using the latest evidence, 
an attempt is made to elucidate whether enhanced neutrophil 
trafficking is a function of uncontrolled inflammation or whether 
specific signals drive neutrophil production during tuberculosis. 
These mechanisms span over a multitude of cytokines, leukot-
rienes, complement factors, adaptor molecules, and receptors 
whose expression may be found ultimately to be dysregulated as 
a factor of host genetic aberrations.
SUSCePTiBiLiTY TO TUBeRCULOSiS iS 
ASSOCiATeD wiTH A HigHeR 
ABUNDANCe, iNCReASeD MigRATORY 
CAPACiTY, AND HeTeROgeNeiTY OF 
NeUTROPHiLS
Immune hyperreactivity underlies the development of tuberculosis 
disease and is characterized by an over secretion of proinflamma-
tory cytokines and chemokines, exacerbated T cell responses, and 
increased neutrophil infiltration in the lungs (20). Neutrophils 
are the most abundant immune cell found in the bronchoalveo-
lar lavage (BAL) and sputum of active pulmonary tuberculosis 
patients, and in the lungs are second only to lymphocytes (9).
The early immune response to M. tb infection is not possible to 
assess in human subjects; however, mice studies of susceptibility 
have been able to capture these early immune events with regard 
to the response of granulocytes soon after mycobacterial infec-
tion. Common characteristics of neutrophils from susceptible 
mouse strains indicate that they have an intrinsically higher 
migration activity, which does not depend on the presence of 
an infectious stimulus (29). It has been observed that in both 
I/St and DBA/2 susceptible mouse strains, there is a significant 
influx of neutrophils early on after infection when compared 
to the resistant strains (29, 30). Since these mice are bred for 
susceptibility, this cause of this response is attributed to host-
based genetics that are independent of the infectious agent. In 
both mice and humans, M. tb is still not cleared effectively in 
susceptible hosts, despite the increased number of neutrophils 
at the infection site. Up until now, it was unknown whether the 
abundance of neutrophils just days after infection promote M. tb 
survival. Recent work suggests that this hyperreactive influx early 
on primes the affected tissue for mycobacterial clinical persistence: 
it was demonstrated that granulocytic inflammation generates a 
nutrient-replete niche that supports M. tb growth, specifically M. 
tb that grow in association with neutrophils encounter a more 
hospitable environment that is replete with micronutrients, such 
as iron and lipid carbon sources (13). This finding proposes that 
this early influx may promote M. tb replication and, therefore, 
disease progression. A study in patients with recent tuberculosis 
(patients had not yet received anti-tuberculosis therapy), observed 
neutrophilia as a common characteristic among patients and a 
correlation between pulmonary pathology and band neutrophils 
was confirmed (20). Generally, elevated band counts (bandemia) 
suggest serious bacterial infection; however, it is not suggested as 
parameter for the diagnosis of infection (31). In the context of early 
tuberculosis, it may, therefore, be an indication of hyperactivity of 
the granulocyte response to infection in susceptible individuals. 
It may, therefore, be inferred that the main difference in the early 
neutrophil response to M. tb infection between susceptible and 
resistant individuals is (i) the number of neutrophils at the site 
of infection early post-infection, (ii) the ability of neutrophils to 
phagocytose, but not eliminate M. tb despite these high numbers 
and finally, (iii) the inability of these neutrophils to effectively 
communicate with other immune cells to activate an efficient 
adaptive immune response (discussed below).
In advanced tuberculosis, neutrophil abundance is an over-
whelming feature associated with disease severity. In order to 
accommodate this influx, other cells, such as the endothelium 
are also primed as a consequence. It was observed that the 
endothelial mediators of neutrophil migration, namely l-selectin, 
E-selectin, and ICAM-1 are upregulated in active tuberculosis 
(32), which correlates with the observation that neutrophils 
are present at sites of active mycobacterial disease (9, 33, 34). 
Neutrophil trafficking seems to be in-part, associated with 
the expression of programed death-1 (PDL-1), since PD-1 or 
PDL-1 knockout mice show exaggerated pathology and excess 
neutrophil influx (35). In the case of active tuberculosis, however, 
PDL-1 is overexpressed by neutrophils (36), which suggests that 
either PDL-1 excess or deficiency may result in neutrophil- 
associated pathology that is linked to exacerbated influx (18). 
This effect is likely to be indirect since PDL-1 expression has 
been shown to inhibit T-cell effector functions during tubercu-
losis disease (37) and may explain the delayed accumulation of 
T-cell responses within the lung that (i) diminish communica-
tion between the adaptive and innate immune systems and (ii) 
prevent clearance of M. tb, leading to latency (38). An interesting 
concept of “adaptive neutrophils” was introduced through a 
mouse study of M. tb infection where the authors describe that 
upon the onset of the adaptive immune response, an influx of 
neutrophils, together with T-cells were recruited to the lung (25). 
It is interesting to note that these neutrophils did not associate 
with the bacteria, but rather interacted closely with T-cells. This 
non-phagocytic nature is unusual for neutrophils and suggests 
an altered neutrophil phenotype exists during established dis-
ease. The emerging concept of neutrophil heterogeneity that is 
observed in the blood of tuberculosis patients and mouse studies 
of M. tb infection supports this observation. Both human and 
mouse models of late-stage infection indicate that the neutrophil 
population is composed of different subsets that differ in their 
functional properties, phenotype, and levels of maturity. It is 
now known that the commensal microbiota regulate steady-state 
granulopoeisis by regulating G-CSF production (39), and it has 
been hypothesized that since neutrophils play a prominent role 
in containing infections, microbes may dictate multiple aspects 
of neutrophil biology. A study exemplifying this was based on 
analyzing the susceptibility of mice preconditioned by mild or 
severe systemic inflammatory response syndrome (SIRS) to 
Staphylococcus aureus infection (40). Neutrophils from mice with 
severe SIRS produce IL-10, are CD49dneg CD11bhi and uniquely 
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express toll-like receptor-7 (TLR7). In contrast, those neutrophils 
from mice with mild SIRS are resistant to S. aureus and produce 
IL-12, uniquely express TLR5 and 8, and are CD49d+. Further, 
it was demonstrated that these neutrophil subsets activate 
macrophages with varying polarity in  vitro, indicating that 
these subsets may shape environments, which are microbicidal, 
inflammatory, or immunosuppressive (40). More importantly, 
the presence of neutrophils with immunosuppressive or hyper-
inflammatory characteristics may underpin the susceptibility to 
infections.
Low-density granulocytes (LDG) have recently emerged as 
one of the subsets found in patients with advanced tuberculosis 
disease (24). Transcriptomics reveal that these LDGs exhibit sig-
natures, which correlate best with an immature phenotype, which 
is based on the expression of mRNA associated with granule 
enzymes and bactericidal proteins (41). In the same study, LDGs 
exhibited decreased phagocytic activity, enhanced survival, and 
an increased secretion of pro-inflammatory cytokines. The release 
of these immature neutrophils from the bone marrow is hypoth-
esized to be a result of stress and that the presence of specific 
cytokines arrests neutrophil maturation (42). Myeloid-derived 
suppressor cells (MDSC) are present at higher frequencies in 
tuberculosis patients when compared to healthy controls and 
have been shown to have T cell suppressive effects and a higher 
inflammatory response in coculture (43, 44). In mice, these 
MDSCs accumulated in tuberculosis-susceptible mouse strains 
(21, 22) and show low Gr-1/Ly-6G expression, which accompa-
nied a significant decrease in the number of the typical Gr-1/
Ly-6Ghi neutrophil phenotype (23). Evidence suggests that M. 
tb fosters the generation of MDSCs in bone marrow, and that 
susceptibility to infection and lethal inflammation is associated 
with systemic accumulation of MDSCs and the presence of 
MDSC-like cells in the lung parenchyma (23). Furthermore, it 
was demonstrated that MDSC accumulation is part of the general 
inflammatory response to M. tb infection and that the dynamics 
of MDSCs is augmented in a susceptible host developing primary 
progressive tuberculosis (22). Both clinical and murine studies 
agree that these cells phagocytose and “harbor” M. tb, suppress 
T-cell function, and accumulate in susceptible mice/infected 
individuals during the late stages of tuberculosis disease.
In studies describing the presence of these neutrophil-like 
cells found in advanced tuberculosis, it is evident that the total 
number of “true” neutrophils is reduced, additionally, these 
neutrophil-like cells have the following characteristics in com-
mon, (i) phenotypic and biochemical features of immaturity, (ii) 
observed to dampen T-cell responses, (iii) hyperinflammatory, 
and (iv) prolonged survival (discussed below). Chemotactic 
factors, as well as intracellular signaling promoting directional 
migration essentially governs the influx of neutrophils to sights 
of inflammation; however in tuberculosis, aberrant signaling, 
whether inherent or induced may contribute to the granulocyte 
hyperreactivity that is observed in susceptible individuals.
THe ROLe OF Pi3-KiNASe SigNALiNg iN 
SHAPiNg THe NeUTROPHiL ReSPONSe
Disruptions in PI3-kinase signaling can influence a multitude 
of cells, especially those in which neutrophils play a dominant 
role. Increased PI3-K activity, in particular, has been shown to 
compromise the migratory accuracy of neutrophils, thereby 
prolonging their tissue transit time, which leads to bystander tis-
sue injury mediated by surface-associated neutrophil proteases 
(28). Class I PI3-kinases (α, β, γ, and δ) function to promote 
the directional migration of neutrophils after activation by 
chemoattractants (45). Recently, a study revealed for the first 
time that PI3-K α, β, and δ together orchestrate hematopoietic 
homeostasis, with PI3-K δ being required specifically for leuko-
cyte development (46). It was further elucidated that deficiencies 
in PI3-Kγ and δ induced neutrophilia by enhancing signaling 
through the IL-17/G-CSF axis (47). Both γ and δ isoforms have 
distinct roles in chemokine-induced neutrophil migration (48). 
The class II PI3-kinases (C2α, C2β, and C2γ) are suggested to play 
a potential role in agonist-mediated regulation of cellular func-
tions. PI3K-C2β specifically is implicated in the differentiation 
of hematopoetic cells by retinoic acid (49). Retrospectively, we 
observe evidence from blood transcriptional signatures in mouse 
and human studies of tuberculosis disease, which indicate that 
circulating neutrophils exhibit altered expression in those genes 
encoding various PI3-K polypetide/substructures and negative 
regulators of PI3-K. This will be discussed in more detail below.
PIK3CD eXPReSSiON MODULATeS THe 
iL-17/g-CSF AXiS AND NeUTROPHiL 
CHeMOTAXiS iN TUBeRCULOSiS
G-CSF drives neutrophil proliferation and differentiation and 
its secretion is dependent on IL-17 signaling upstream (50). In 
response to G-CSF, PI3-K δ (PIK3CD) produces second messen-
ger signaling molecules, which promote neutrophil movement in 
response to chemotactic stimuli (51). Interestingly, PI3-K δ has 
been implicated in intracellular IL-17 signaling (52) and TH17 cell 
differentiation (53). In a mouse study of tuberculosis susceptibil-
ity, total lung RNA from two susceptible mouse strains (DBA/2 
and CBA/J) was analyzed 4 weeks post-infection by Affymetrix 
GeneChip U74 array (30). It was observed that Pik3cd was signifi-
cantly upregulated in whole lung tissue, along with Il17ra (IL-17 
receptor), both of which were not differentially regulated in lung 
tissue of resistant mouse strains. In the same study, analysis 
revealed that transcriptomics of the affected lung tissue correlated 
with excessive neutrophil influx into the lungs and a bias toward 
the expression of genes involved in granulocyte pathophysiology. 
Interestingly, another murine study observed that IL-17RA in 
non-hematopoietic cells (epithelial and endothelial cells, as well 
as fibroblasts) is critical for neutrophil recruitment to the lung 
(25). Evidence also suggests that a decrease/loss in function of 
PI3-K δ also affects IL-17-mediated neutrophil recruitment. This 
was exemplified in a murine study where it was observed that a 
deficiency in expression of PI3-K δ, along with PI3-K γ, enhances 
the IL-17/G-CSF axis and induces neutrophilia (47). Additionally, 
it was noted that a deficiency in these sub-units leads to defective 
B- and T-cell homeostasis, which underscores their role in effec-
tive adaptive immune response activation.
The intracellular presence of M. tb itself also appears to 
directly affect the expression of PIK3CD. A recent study investi-
gated PI3-K δ signaling in lung lesions of patients with confirmed 
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pulmonary tuberculosis and observed that the expression of 
PI3-K δ is globally absent throughout tuberculosis granulomas, 
but present in normal lung tissue from healthy individuals (54). 
The same study showed that during early infection, M. tb disables 
the genes encoding PI3-K δ/AKT/mTORC1 and MNK regula-
tory pathways by upregulating a network of microRNAs with 
sequences targeting the 3′UTRs regions (54). Disruption of this 
pathway then promotes a tissue-destructive phenotype through 
MMP-1 upregulation, which promotes lung cavitation. Thus, 
in granulomas, PI3-K δ is absent; however, the authors do not 
indicate what the level of expression is in the surrounding lung 
tissue. This finding is supported by another study that showed 
that the PI3-K pathway is the key regulator of interleukin-17 
driven MMP secretion by airway epithelial cells (55). Evidence 
from both humans and mice suggests that both a loss and gain in 
function of PIK3CD/PI3-K δ leads to disruption of the G-CSF/
IL-17 pathway leading to neutrophil hyperreactivity and ineffec-
tive communication between the innate and adaptive immune 
system.
PIK3IP1, A NegATive RegULATOR  
Pi3-K p110, iS DOwNRegULATeD iN 
PeRiPHeRAL LeUKOCYTeS FROM 
PATieNTS wiTH TUBeRCULOSiS
Downstream signaling regulation of the PI3-K pathway is central 
in maintaining intracellular homeostatic conditions and is con-
trolled by a number of regulators. To date, phosphatase and tensin 
homolog deleted on chromosome 10 (PTEN), inositol polyphos-
phate 4-phosphatase type II (INPP4B), and SH2 containing 
inositol 5′-phosphatase (SHIP-1) are well-characterized negative 
regulators of the PI3-K pathway, all of which act downstream of 
PI3-K. Recently, PI3-K interacting protein 1 (PIK3IP1) has also 
been described as a negative regulator of PI3-K and inhibits its 
activity upstream through proximal allosteric interference with 
class I PI3K catalytic subunits p110 α, β, and δ (56, 57). To date, 
there is no information regarding the biological role of PIK3IP1 
during tuberculosis infection; however, it may play a part in dis-
ruption of the normal life/death time-course of the extravasated 
neutrophil. Given the propensity of neutrophils to die by “consti-
tutive” apoptosis when utilized for in vitro studies, the major chal-
lenge in airway research is to determine how and why neutrophils 
persist in such a large numbers in the lung. Transcriptomics from 
tuberculosis patients indicate (i) that PIK3IP1 is part of the tran-
scriptomic signature that discriminates tuberculosis from other 
inflammatory infections and diseases and (ii) that its expression 
is downregulated in circulating neutrophils in comparison to 
healthy controls (15). Its downregulation was further confirmed 
in two other whole blood transcriptomic-based tuberculosis 
studies (58, 59). The consequences of PIK3IP1 on PI3K signaling 
was elucidated in hepatic cell lines where motility and apoptosis 
was assessed. It was observed that PIK3IP1 expression suppressed 
motility and promoted apoptosis in isolated mouse hepatocytes 
in a PI3-K-dependant manner (60). Although a similar effect can-
not be assumed to occur in the leukocyte, the regulatory role that 
PIK3IP1 may play in apoptosis and motility cannot be ignored 
and requires further investigation.
PIK3C2B iS DOwNRegULATeD iN 
PeRiPHeRAL LeUKOCYTeS FROM 
PATieNTS wiTH TUBeRCULOSiS
PIK3C2B encodes the class II enzymatic isoform C2β, which 
has a wide tissue distribution and is found to be expressed in 
lymphocytes. Blood transcriptomics of patients with tuberculosis 
revealed that that PIK3C2B is downregulated when compared to 
individuals with latent tuberculosis infection (15, 58, 59). Little 
evidence is available regarding the role of this class II PI3K under 
normal and disease conditions in the context of the whole organ-
ism. Interestingly though, studies of PI3KC2β−/− mice have 
demonstrated that while PI3K-C2β−/− mice exhibit no obvious 
phenotypic abnormalities (61), they exhibit increased insulin 
sensitivity and glucose tolerance, and are resistant to high-fat 
diet-induced steatosis (62). Additionally, in the few studies that 
have been conducted, it appears that C2β generates PI3P, which 
is essential for receptor activation of various cell types, specifi-
cally, the proliferation of T-cells and activation of their TCRs (63, 
64), B-cell receptor signaling (65), and most recently, mast cell 
activation through IgE receptor stimulation (66). Further, phar-
macological inhibition of C2β is proposed to have therapeutic 
potential in diseases, which are IgE-associated (67). In the context 
of tuberculosis, however, the average downregulation of this gene 
across peripheral blood leukocytes in affected individuals sug-
gests an overall dampening of the immune system. Future studies 
should assess the role of this protein during tuberculosis disease 
and whether PI3P intracellular levels are affected as this ultimately 
interferes with receptor activation and as a consequence, com-
munication between the innate and adaptive immune systems.
CONCLUDiNg ReMARKS
Taken together, evidence from both mouse and human studies 
suggests a strong correlation between neutrophil hyper-reactivity 
in the tuberculosis-susceptible host. Early infection events indi-
cate a higher-than-average influx of neutrophils to the infection 
site which appears to facilitate and promote M. tb growth (13). 
Evidence from transcriptomic studies indicate aberrations in 
gene expression of key molecules of the PI3-kinase pathway, as 
well as their regulators during tuberculosis disease. Notable roles 
of these molecules include modulating the IL-17/G-CSF axis, 
inducing leukocyte receptor activation, and regulating apoptosis 
and motility. Thus, the PI3–kinase pathway may play an especially 
prominent role in neutrophils of susceptible individuals and may 
be an intrinsic cause of tuberculosis disease severity and progres-
sion and, therefore, warrants further investigation.
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